How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,486 results for

"covid 19" OR "novel coronavirus"

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Chloroquine phosphate for novel coronavirus (COVID-19) pneumonia : a systematic review and meta-analysis of randomised controlled trials

Chloroquine phosphate for novel coronavirus (COVID-19) pneumonia : a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

22. A systematic review of convalescent plasma treatment for SAR coronavirus and MERS coronavirus: a possible reference for a 2019 novel coronavirus (COVID-19) treatment option

A systematic review of convalescent plasma treatment for SAR coronavirus and MERS coronavirus: a possible reference for a 2019 novel coronavirus (COVID-19) treatment option Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

23. Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a systematic review and meta-analysis

Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

24. The risk factors of acquiring severe 2019 novel coronavirus (COVID-19): a meta-analysis

The risk factors of acquiring severe 2019 novel coronavirus (COVID-19): a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

25. The risk factors for death from 2019 novel coronavirus (COVID-19)-infected pneumonia

The risk factors for death from 2019 novel coronavirus (COVID-19)-infected pneumonia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

26. Prevalence and characteristics of fever in novel coronavirus (COVID-19)-infected adult and paediatric patients:a systematic review and meta-analysis of first three-month data of the outbreak

Prevalence and characteristics of fever in novel coronavirus (COVID-19)-infected adult and paediatric patients:a systematic review and meta-analysis of first three-month data of the outbreak Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

27. Prevalence of symptoms and comorbid conditions in novel coronavirus (COVID-19)-infected adult and paediatric patients: a systematic review and meta-analysis of first three-month data of the outbreak

Prevalence of symptoms and comorbid conditions in novel coronavirus (COVID-19)-infected adult and paediatric patients: a systematic review and meta-analysis of first three-month data of the outbreak Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2020 PROSPERO

28. Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials

Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

29. The rehabilitative effects of traditional Chinese exercise in patients with novel coronavirus pneumonia (COVID-19): a systematic review and meta-analysis

The rehabilitative effects of traditional Chinese exercise in patients with novel coronavirus pneumonia (COVID-19): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

30. The psychological impact of 2019 novel coronavirus pneumonia (COVID-19)and mental healthcare strategies: a systematic review and meta-analysis of current evidence

The psychological impact of 2019 novel coronavirus pneumonia (COVID-19)and mental healthcare strategies: a systematic review and meta-analysis of current evidence Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

31. Answering the global call for action in rapid practice guidelines for the management of people with the novel Coronavirus COVID-19: protocol for a rapid systematic review

Answering the global call for action in rapid practice guidelines for the management of people with the novel Coronavirus COVID-19: protocol for a rapid systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

32. A protocol for a systematic review and meta-analysis of Siddha Medicines having Anti viral activity and beneficial in reducing symptoms and selected as candidates for treating novel coronavirus disease (COVID-19)

A protocol for a systematic review and meta-analysis of Siddha Medicines having Anti viral activity and beneficial in reducing symptoms and selected as candidates for treating novel coronavirus disease (COVID-19) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD

2020 PROSPERO

33. The effects and safety of lopinavir combined with ritonavir for novel coronavirus (COVID-19) pneumonia: a systematic review and meta-analysis

The effects and safety of lopinavir combined with ritonavir for novel coronavirus (COVID-19) pneumonia: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

34. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of observational studies

Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

35. Clinical features and imaging findings of novel coronavirus pneumonia (COVID-19), a systematic review and meta-analysis

Clinical features and imaging findings of novel coronavirus pneumonia (COVID-19), a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2020 PROSPERO

36. Clinical practice guidelines of traditional Chinese herbal medicine for novel coronavirus(COVID-19): a systematic review

Clinical practice guidelines of traditional Chinese herbal medicine for novel coronavirus(COVID-19): a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2020 PROSPERO

37. Efficacy and safety of Favipiravir compared with other treatments for novel coronavirus (COVID-19)

Efficacy and safety of Favipiravir compared with other treatments for novel coronavirus (COVID-19) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2020 PROSPERO

38. The efficacy and safety of tested treatments for novel coronavirus pneumonia (COVID-19): a systematic review and network meta-analysis clinical trials

The efficacy and safety of tested treatments for novel coronavirus pneumonia (COVID-19): a systematic review and network meta-analysis clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

39. Efficacy and safety of ribavirin in the treatment of novel coronavirus (COVID-19) pneumonia: a systematic review and meta-analysis

Efficacy and safety of ribavirin in the treatment of novel coronavirus (COVID-19) pneumonia: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2020 PROSPERO

40. Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19) in rehabilitation period: a systematic review and meta-analysis

Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19) in rehabilitation period: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>